Manica Balasegaram
politicianMale0.0Global Dominance: 0.00%
Dr. Manica Balasegaram is the executive director of the Global Antibiotic Research and Development Partnership and has been instrumental in the development and clinical trials of new treatments for gonorrhea, emphasizing the importance of accessible treatment amid rising drug resistance.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Dr Manica Balasegaram, executive director of GARDP, stated that the approval marks a huge turning point in the treatment of multidrug-resistant gonorrhoea.
New antibiotics hailed as ‘turning point’ in treating drug-resistant gonorrhoea | Global healthThe Guardian·
United Kingdom· 2025-12-16
United Kingdom· 2025-12-16
Dr. Manica Balasegaram, executive director of the Global Antibiotic Research and Development Partnership, highlighted the advantages of the new treatment options.
FDA approves first new antibiotics to treat gonorrhea in decades, with hope to combat drug resistanceCNN·
United States· 2025-12-12
United States· 2025-12-12
Dr Manica Balasegaram is executive director of the Global Antibiotic Research and Development Partnership.
‘As new infections outpace new drugs, are we sleepwalking into a global health disaster?’ | Dr Manica BalasegaramThe Guardian·United Kingdom· 2025-10-14
United Kingdom· 2025-10-14